Treventis Awarded $2.97M Grant from the U.S. Department of Defense
Treventis Awarded $2.97M Grant from the U.S. Department of Defense
Funds for Development of Its Anti-Tau Drug Against Neurodegenerative Diseases
Comments are closed.
Treventis Awarded $2.97M Grant from the U.S. Department of Defense
Funds for Development of Its Anti-Tau Drug Against Neurodegenerative Diseases